- Previous Close
0.0000 - Open
0.0002 - Bid 0.0001 x --
- Ask 0.0002 x --
- Day's Range
0.0002 - 0.0002 - 52 Week Range
0.0001 - 0.0012 - Volume
10,000 - Avg. Volume
2,634,488 - Market Cap (intraday)
248,222 - Beta (5Y Monthly) 1.40
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.
www.globestartherapeutics.comRecent News: GSTC
View MorePerformance Overview: GSTC
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GSTC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GSTC
View MoreValuation Measures
Market Cap
248.22k
Enterprise Value
578.36k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-919.3k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
41
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--